Literature DB >> 21607043

Breast ductal carcinoma and metastatic lymphoma to the contralateral breast in patient with cutaneous non-Hodgkin lymphoma.

B Di Nubila, S Meroni, L Bonello, F Peccatori, E Cassano, M Bellomi.   

Abstract

Breast lymphoma is a rare condition, both as a primary and a metastatic manifestation. The primary form has an incidence ranging from 0.04% to 0.5% of all breast neoplasms, whereas the metastatic form has an incidence of 0.07%. We hereby report a clinical case of a patient who presented with cutaneous non-Hodgkin lymphoma (NHL) in the left scapulohumeral region treated with surgery followed by radiotherapy (40 Gy total). Three years following radiotherapy, the patient was diagnosed with a left breast infiltrating ductal carcinoma, treated with conservative surgery and adjuvant therapy. The following year, i.e. four years after the initial diagnosis of NHL, two lymphoproliferative relapses occurred: in the left cutaneous scapulohumeral region at the original site of disease, and in the right breast. The aim of this paper is to highlight an uncommon oncologic disorder such as breast lymphoma, highlighting its clinical and radiological manifestations. Some studies reported a possible aetiological role of radiotherapy in the development of breast cancer following treatment of NHL, and in the development of breast cancer following treatment of Hodgkin lymphoma, which could potentially explain our findings.

Entities:  

Keywords:  breast; lymphoma; radiotherapy

Year:  2011        PMID: 21607043      PMCID: PMC3093153     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  14 in total

1.  Secondary malignancies after therapy of indolent non-Hodgkin's lymphoma.

Authors:  Jonathan W Friedberg
Journal:  Haematologica       Date:  2008-03       Impact factor: 9.941

2.  Risk of subsequent solid tumors after non-Hodgkin's lymphoma: effect of diagnostic age and time since diagnosis.

Authors:  Kari Hemminki; Per Lenner; Jan Sundquist; Justo Lorenzo Bermejo
Journal:  J Clin Oncol       Date:  2008-03-17       Impact factor: 44.544

3.  Breast cancer occurred after treatment for Hodgkin's disease: analysis of 133 cases.

Authors:  B Cutuli; C Borel; F Dhermain; S M Magrini; T H Wasserman; J A Bogart; M Provencio; B de Lafontan; A de la Rochefordiere; E Cellai; Y Graic; P Kerbrat; C Alzieu; E Teissier; J M Dilhuydy; H Mignotte; M Velten
Journal:  Radiother Oncol       Date:  2001-06       Impact factor: 6.280

4.  The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma.

Authors:  Jonathan D Tward; Merideth M M Wendland; Dennis C Shrieve; Aniko Szabo; David K Gaffney
Journal:  Cancer       Date:  2006-07-01       Impact factor: 6.860

5.  The incidence of breast cancer following mantle field radiation therapy as a function of dose and technique.

Authors:  A Tinger; T H Wasserman; E E Klein; E A Miller; T Roberts; J V Piephoff; N A Kucik
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-03-01       Impact factor: 7.038

6.  Solid tumors in patients treated for Hodgkin's disease: a report from the German Hodgkin Lymphoma Study Group.

Authors:  K Behringer; A Josting; P Schiller; H T Eich; H Bredenfeld; V Diehl; A Engert
Journal:  Ann Oncol       Date:  2004-07       Impact factor: 32.976

7.  Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease.

Authors:  Lois B Travis; Deirdre A Hill; Graça M Dores; Mary Gospodarowicz; Flora E van Leeuwen; Eric Holowaty; Bengt Glimelius; Michael Andersson; Tom Wiklund; Charles F Lynch; Mars B Van't Veer; Ingrid Glimelius; Hans Storm; Eero Pukkala; Marilyn Stovall; Rochelle Curtis; John D Boice; Ethel Gilbert
Journal:  JAMA       Date:  2003-07-23       Impact factor: 56.272

Review 8.  Metastatic tumors in the breast: a report of 5 cases and review of the literature.

Authors:  Aras Emre Canda; Ali Ibrahim Sevinc; Mehmet Ali Kocdor; Tulay Canda; Pinar Balci; Serdar Saydam; Omer Harmancioglu
Journal:  Clin Breast Cancer       Date:  2007-06       Impact factor: 3.225

9.  B-cell and T-cell lymphomas of the breast: clinical--pathological features of 53 cases.

Authors:  Gabriela Gualco; Carlos E Bacchi
Journal:  Int J Surg Pathol       Date:  2008-05-14       Impact factor: 1.271

10.  Non-Hodgkin lymphoma of the breast.

Authors:  Kristen Ganjoo; Ranjana Advani; M Rajan Mariappan; Alex McMillan; Sandra Horning
Journal:  Cancer       Date:  2007-07-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.